142 related articles for article (PubMed ID: 32873880)
1. A MXI1-NUTM1 fusion protein with MYC-like activity suggests a novel oncogenic mechanism in a subset of NUTM1-rearranged tumors.
McEvoy CR; Holliday H; Thio N; Mitchell C; Choong DY; Yellapu B; Leong HS; Xu H; Lade S; Browning J; Takano EA; Byrne DJ; Gill AJ; Duong CP; Li J; Fellowes AP; Fox SB; Swarbrick A; Prall OWJ
Lab Invest; 2021 Jan; 101(1):26-37. PubMed ID: 32873880
[TBL] [Abstract][Full Text] [Related]
2. A recurrent novel
Diolaiti D; Dela Cruz FS; Gundem G; Bouvier N; Boulad M; Zhang Y; Chou AJ; Dunkel IJ; Sanghvi R; Shah M; Geiger H; Rahman S; Felice V; Wrzeszczynski KO; Darnell RB; Antonescu CR; French CA; Papaemmanuil E; Kung AL; Shukla N
Cold Spring Harb Mol Case Stud; 2018 Dec; 4(6):. PubMed ID: 30552129
[No Abstract] [Full Text] [Related]
3. Emerging entities in NUTM1-rearranged neoplasms.
McEvoy CR; Fox SB; Prall OWJ
Genes Chromosomes Cancer; 2020 Jun; 59(6):375-385. PubMed ID: 32060986
[TBL] [Abstract][Full Text] [Related]
4. Sarcoma with MGA::NUTM1 fusion: a report of three cases and literature review.
Wangsiricharoen S; Wakely PE; Prieto VG; Yu W
Histopathology; 2023 Nov; 83(5):712-721. PubMed ID: 37442637
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic features of an MXI1::NUTM1 fusion neoplasm; a new molecular variant of the family of NUTM1-rearranged neoplasm.
Duan FL; Hou J; Guo P; Tan H; Dai J; Tang Z; Chen M; Liu Y
Histopathology; 2022 Oct; 81(4):536-539. PubMed ID: 35791777
[No Abstract] [Full Text] [Related]
6. NUTM1-rearranged colorectal sarcoma: a clinicopathologically and genetically distinctive malignant neoplasm with a poor prognosis.
Van Treeck BJ; Thangaiah JJ; Torres-Mora J; Stevens TM; Rothermundt C; Fassan M; Loupakis F; Diebold J; Hornick JL; Halling KC; Folpe AL
Mod Pathol; 2021 Aug; 34(8):1547-1557. PubMed ID: 33714983
[TBL] [Abstract][Full Text] [Related]
7. Induction of Mxi1-SR alpha by FOXO3a contributes to repression of Myc-dependent gene expression.
Delpuech O; Griffiths B; East P; Essafi A; Lam EW; Burgering B; Downward J; Schulze A
Mol Cell Biol; 2007 Jul; 27(13):4917-30. PubMed ID: 17452451
[TBL] [Abstract][Full Text] [Related]
8. NUTM1-rearranged neoplasia: a multi-institution experience yields novel fusion partners and expands the histologic spectrum.
Stevens TM; Morlote D; Xiu J; Swensen J; Brandwein-Weber M; Miettinen MM; Gatalica Z; Bridge JA
Mod Pathol; 2019 Jun; 32(6):764-773. PubMed ID: 30723300
[TBL] [Abstract][Full Text] [Related]
9. Primary Spindle Cell Sarcoma of the Lung with
Georgantzoglou N; Aghighi M; Cote G; Hung YP; Kerr DA; Pettus J; Linos K
Int J Surg Pathol; 2022 Dec; 30(8):931-938. PubMed ID: 35388715
[TBL] [Abstract][Full Text] [Related]
10. N-Myc differentially regulates expression of MXI1 isoforms in neuroblastoma.
Armstrong MB; Mody RJ; Ellis DC; Hill AB; Erichsen DA; Wechsler DS
Neoplasia; 2013 Dec; 15(12):1363-70. PubMed ID: 24403858
[TBL] [Abstract][Full Text] [Related]
11. Suppression of Myc, but not E1a, transformation activity by Max-associated proteins, Mad and Mxi1.
Lahoz EG; Xu L; Schreiber-Agus N; DePinho RA
Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5503-7. PubMed ID: 8202517
[TBL] [Abstract][Full Text] [Related]
12. NUTM1-fusion positive malignant neoplasms of the genitourinary tract: A report of six cases highlighting involvement of unusual anatomic locations and histologic heterogeneity.
Xu B; Chen JF; Sarungbam J; Tickoo S; Dickson BC; Reuter VE; Antonescu CR
Genes Chromosomes Cancer; 2022 Sep; 61(9):542-550. PubMed ID: 35430756
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of Mxi1 inhibits the induction of the human ornithine decarboxylase gene by the Myc/Max protein complex.
Wu S; Peña A; Korcz A; Soprano DR; Soprano KJ
Oncogene; 1996 Feb; 12(3):621-9. PubMed ID: 8637719
[TBL] [Abstract][Full Text] [Related]
14. Evolutionary relationships and functional conservation among vertebrate Max-associated proteins: the zebra fish homolog of Mxi1.
Schreiber-Agus N; Chin L; Chen K; Torres R; Thomson CT; Sacchettini JC; DePinho RA
Oncogene; 1994 Nov; 9(11):3167-77. PubMed ID: 7936639
[TBL] [Abstract][Full Text] [Related]
15. Expression and mutation analysis of genes that encode the Myc antagonists Mad1, Mxi1 and Rox in acute leukaemia.
Guo XL; Pan L; Zhang XJ; Suo XH; Niu ZY; Zhang JY; Wang F; Dong ZR; Da W; Ohno R
Leuk Lymphoma; 2007 Jun; 48(6):1200-7. PubMed ID: 17577784
[TBL] [Abstract][Full Text] [Related]
16. Thyroid Carcinoma with NSD3::NUTM1 Fusion: a Case with Thyrocyte Differentiation and Colloid Production.
Allison DB; Rueckert J; Cornea V; Lee CY; Dueber J; Bocklage T
Endocr Pathol; 2022 Jun; 33(2):315-326. PubMed ID: 34997561
[TBL] [Abstract][Full Text] [Related]
17. NUTM1 Gene Fusions Characterize a Subset of Undifferentiated Soft Tissue and Visceral Tumors.
Dickson BC; Sung YS; Rosenblum MK; Reuter VE; Harb M; Wunder JS; Swanson D; Antonescu CR
Am J Surg Pathol; 2018 May; 42(5):636-645. PubMed ID: 29356724
[TBL] [Abstract][Full Text] [Related]
18. The expanding universe of NUTM1 fusions in pediatric cancer.
Charlab R; Racz R
Clin Transl Sci; 2023 Aug; 16(8):1331-1339. PubMed ID: 37082775
[TBL] [Abstract][Full Text] [Related]
19. Primary malignant epithelioid and rhabdoid tumor of bone harboring ZNF532-NUTM1 fusion: the expanding NUT cancer family.
Chien YW; Hsieh TH; Chu PY; Hsieh SM; Liu ML; Lee JC; Liu YR; Ku JW; Kao YC
Genes Chromosomes Cancer; 2019 Nov; 58(11):809-814. PubMed ID: 31334571
[TBL] [Abstract][Full Text] [Related]
20. Dynamic in vivo interactions among Myc network members.
Yin X; Landay MF; Han W; Levitan ES; Watkins SC; Levenson RM; Farkas DL; Prochownik EV
Oncogene; 2001 Aug; 20(34):4650-64. PubMed ID: 11498788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]